Xiaodong. Zhang, et.al., Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis., Diabetes, 2014, 63

http://rdf.ncbi.nlm.nih.gov/pubmed/24194501

Xiaodong. Zhang, et.al., Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis., Diabetes, 2014, 63

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal liver morphology_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0000598IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased body weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0001262IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased susceptibility to hepatic steatosis_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0002310IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased liver weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0003402IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased omental fat pad weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0010046IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased inguinal fat pad weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0009293IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased circulating alanine transaminase level_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0002942IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased circulating insulin level_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0002727IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased brown adipose tissue amount_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0001780IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• increased circulating free fatty acid level_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0001554IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased liver triglyceride level_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0009356IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased circulating aspartate transaminase level_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0005632IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased gonadal fat pad weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0009283IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• increased insulin sensitivity_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0002891IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased renal fat pad weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0009303IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• abnormal white adipose tissue physiology_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0005670IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• decreased kidney weight_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0003918IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• enhanced lipolysis_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0008034IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg
• improved glucose tolerance_G0s2<tm1(KOMP)Vlcg>/G0s2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/0005292IC57BL6NTacG0s2tm1KOMPVlcgG0s2tm1KOMPVlcgG0s2tm1KOMPVlcg